SEC Form 4 · accession 0001209191-15-005846
Sesen Bio, Inc. · SESN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry Gertz
Director
Period of report
Jan 20, 2015
Accepted (ET)
Jan 22, 2015 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001485003
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $11.85 | Jan 20, 2015 | A | 16,143 | A | — | Jan 19, 2025 | Common Stock | 16,143 | 16,143 | D |
Explanation of responses
- F1This option was granted on January 20, 2015 and vests over three years, with 1/36th of the shares subject to the option vesting at the end of each successive one-month period following the grant date.